Signaling pathways
-
BA8207 OlprinoneSummary: Olprinone (Loprinone) is a potent phosphodiesterase inhibitor with 150, 100, 0.35, and 14 μM for PDE1, PDE2, PDE3, and PDE4, respectively. - BA8208 CP671305Summary: The CP671305 is an effective.
- BA8209 AN3199Summary: AN3199 is an inhibitor.
- BA8210 TanimilastSummary: Tanimilast (CHF-6001) is a novel potent and selective inhibitor (=0.026±0.006nM) with potent anti-inflammatory activity suitable for topical pulmonary administration.
- BA8211 LirimilastSummary: Lirimilast (BAY19-8004) is a potent, selective and orally active phosphodiesterase 4 inhibitor.
- BA8212 Hcyb1Summary: Hcyb1 is a highly selective, orally active inhibitor.
- BA8213 YonkenafilSummary: Yonkenafil (Tunodafil) is a novel phosphodiesterase 5 inhibitor that is effective in reducing cerebral infarction, neurological deficits, edema, and neuronal damage in the infarcted area.
- BA8214 BIO-32546Summary: BIO-32546 (S-isomer) is the regulator.
- BA8215 PDE4-IN-14Summary: PDE4-IN-14 is an inhibitor.
- BA8216 RobustineSummary: A furanquinoline alkaloid.